ISSN 2639-9431
Vol. 8, Issue ICRAN, 2025December 06, 2025 EDT
Targeted Delivery of Raloxifene via RGD-functionalized Chitosan Nanoparticle Selectively Attenuates Breast Tumor Growth
Targeted Delivery of Raloxifene via RGD-functionalized Chitosan Nanoparticle Selectively Attenuates Breast Tumor Growth
Articles in Vol. 8, Issue ICRAN, 2025
Vol. 8, Issue ICRAN, 2025
- New Prospects for Therapeutic Organic NanocrystalsNathalie Mignet
- Advances and Challenges in Tumor- and Stroma-Targeted Theranostic Nanoparticles for Treating Therapy-Resistant CancerLily Yang
- From lipid biophysics to first-in human test: topical liposomal treatment for cutaneous leishmaniasisDolores Catalina Carrer
- Food is Medicine: Next Steps Towards Feeding the World Using Nanotechnology LawIlise Feitshans
- Targeted Delivery of Raloxifene via RGD-functionalized Chitosan Nanoparticle Selectively Attenuates Breast Tumor GrowthSuryendu SahaAmit S. YadavGopal C. Kundu
- Inhibiting Molecular Intracellular Targets in CancerSimo SchwartzJoaquim Seras-FrancosoZamira V. Dias-RiascosConxita Jacobs-CacháFernanda AndradeDiana RafaelRoser Ferrer
- International Conference on Recent Advances in NanomedicineMrutyunjay Suar
Saha, Suryendu, Amit S. Yadav, and Gopal C. Kundu. 2025. “Targeted Delivery of Raloxifene via RGD-Functionalized Chitosan Nanoparticle Selectively Attenuates Breast Tumor Growth.” Precision Nanomedicine 8 (ICRAN): 1659–62. https://doi.org/10.33218/001c.147875.